Could Reimbursement for AI Solutions Really Be That Tricky?

It would be almost impossible to ignore the recent artificial intelligence explosion in healthcare. There have been numerous approvals, clearances, and companies that are developing various solutions with AI capabilities. Some firms have taken the forefront with solutions that could really impact the healthcare landscape. While AI is being readily accepted – there are still some questions surrounding its reimbursement from the Centers for Medicare and Medicaid Services. During Cleveland Clinic’s 2018 Medical Innovation Summit, which was held earlier this week, Eric Hargan, Deputy Secretary, Health and Human Services spoke with MD+DI about AI and how it can potentially be in a grey area. “The process by which software is integrated into medical care is a hard thing to quantify,” Hargan told MD+DI from the media room at the Innovation Summit. “Normally if you have software embedded in – say a pacemaker - it’s easy to know what the software is doing. But when you venture out where technology is starting to do things like possibly analyze a disease state or support clinical decisions, you end up with something where the program in itself is seeming to participate in medicine. It’s analyzing and diagnosing things.” He added, “how do we deal with that? From a reimbursement point of view, how do we have an...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news